Continuation of growth hormone therapy versus placebo in transition-phase patients with growth hormone deficiency: impact on body composition, insulin sensitivity, and thyroid function

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning

Standard

Continuation of growth hormone therapy versus placebo in transition-phase patients with growth hormone deficiency : impact on body composition, insulin sensitivity, and thyroid function. / Jørgensen, Jens; Nørrelund, Helene; Vahl, Nina; Juul, Anders; Skakkebaek, Niels E; Christiansen, Jens Sandahl.

I: Journal of Pediatric Endocrinology and Metabolism, Bind 15 Suppl 5, 2002, s. 1355-60.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning

Harvard

Jørgensen, J, Nørrelund, H, Vahl, N, Juul, A, Skakkebaek, NE & Christiansen, JS 2002, 'Continuation of growth hormone therapy versus placebo in transition-phase patients with growth hormone deficiency: impact on body composition, insulin sensitivity, and thyroid function', Journal of Pediatric Endocrinology and Metabolism, bind 15 Suppl 5, s. 1355-60.

APA

Jørgensen, J., Nørrelund, H., Vahl, N., Juul, A., Skakkebaek, N. E., & Christiansen, J. S. (2002). Continuation of growth hormone therapy versus placebo in transition-phase patients with growth hormone deficiency: impact on body composition, insulin sensitivity, and thyroid function. Journal of Pediatric Endocrinology and Metabolism, 15 Suppl 5, 1355-60.

Vancouver

Jørgensen J, Nørrelund H, Vahl N, Juul A, Skakkebaek NE, Christiansen JS. Continuation of growth hormone therapy versus placebo in transition-phase patients with growth hormone deficiency: impact on body composition, insulin sensitivity, and thyroid function. Journal of Pediatric Endocrinology and Metabolism. 2002;15 Suppl 5:1355-60.

Author

Jørgensen, Jens ; Nørrelund, Helene ; Vahl, Nina ; Juul, Anders ; Skakkebaek, Niels E ; Christiansen, Jens Sandahl. / Continuation of growth hormone therapy versus placebo in transition-phase patients with growth hormone deficiency : impact on body composition, insulin sensitivity, and thyroid function. I: Journal of Pediatric Endocrinology and Metabolism. 2002 ; Bind 15 Suppl 5. s. 1355-60.

Bibtex

@article{68383eb35a324d0bab986f62a035b977,
title = "Continuation of growth hormone therapy versus placebo in transition-phase patients with growth hormone deficiency: impact on body composition, insulin sensitivity, and thyroid function",
abstract = "In a placebo-controlled, parallel study of 18 patients with a mean age of 20 years who had confirmed growth hormone (GH) deficiency, we evaluated body composition, insulin sensitivity, and glucose turnover at baseline (when all were receiving GH replacement); after 12 months of continued GH therapy or placebo; and after a 12-month open phase of GH therapy. In the placebo group, insulin sensitivity and fat mass increased and lipid oxidation decreased, whereas glucose oxidation increased (p",
author = "Jens J{\o}rgensen and Helene N{\o}rrelund and Nina Vahl and Anders Juul and Skakkebaek, {Niels E} and Christiansen, {Jens Sandahl}",
year = "2002",
language = "English",
volume = "15 Suppl 5",
pages = "1355--60",
journal = "Journal of Pediatric Endocrinology and Metabolism",
issn = "0334-018X",
publisher = "Walterde Gruyter GmbH",

}

RIS

TY - JOUR

T1 - Continuation of growth hormone therapy versus placebo in transition-phase patients with growth hormone deficiency

T2 - impact on body composition, insulin sensitivity, and thyroid function

AU - Jørgensen, Jens

AU - Nørrelund, Helene

AU - Vahl, Nina

AU - Juul, Anders

AU - Skakkebaek, Niels E

AU - Christiansen, Jens Sandahl

PY - 2002

Y1 - 2002

N2 - In a placebo-controlled, parallel study of 18 patients with a mean age of 20 years who had confirmed growth hormone (GH) deficiency, we evaluated body composition, insulin sensitivity, and glucose turnover at baseline (when all were receiving GH replacement); after 12 months of continued GH therapy or placebo; and after a 12-month open phase of GH therapy. In the placebo group, insulin sensitivity and fat mass increased and lipid oxidation decreased, whereas glucose oxidation increased (p

AB - In a placebo-controlled, parallel study of 18 patients with a mean age of 20 years who had confirmed growth hormone (GH) deficiency, we evaluated body composition, insulin sensitivity, and glucose turnover at baseline (when all were receiving GH replacement); after 12 months of continued GH therapy or placebo; and after a 12-month open phase of GH therapy. In the placebo group, insulin sensitivity and fat mass increased and lipid oxidation decreased, whereas glucose oxidation increased (p

M3 - Journal article

VL - 15 Suppl 5

SP - 1355

EP - 1360

JO - Journal of Pediatric Endocrinology and Metabolism

JF - Journal of Pediatric Endocrinology and Metabolism

SN - 0334-018X

ER -

ID: 48484118